The Therapeutic Goods
Administration has released several
new Australian Public Assessment
Reports for prescription medicines.
The new AusPARs relate to
the assessment processes for
Flutiform (fluticasone proprionate/
eformoterol fumarate dihidrate),
Picato gel (ingenol mebutate),
Myfortic (micophenolate sodium),
Juvicor/Xelezor/Tesozor (sitagliptin/
simvastatin) and Caprelsa
(vandetanib) - see www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 18 Sep 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 Sep 13
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.